SWERX Performance — Schwab Target 2040 Fund
Data updated: 2026-09-24
SWERX returned +8.18% year to date and +17.03% over one year to Jul 2026. Annualised returns are +14.13% over 3 years and +7.50% over 5 years. The fund beat its Target-Date category average: $100 invested three years ago grew to $149, against $146 for the category, and to $117 over one year, against $116. Volatility over the past three years was 10.70% a year. In the 12 months to Jul 2026 the fund lost a net $51.3M, and assets reached $1.32B.
SWERX Growth of $100
What $100 invested in Schwab Target 2040 Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Target-Date category average over the same months.
| Period | SWERX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $117 | $116 |
| 3 years (Aug 2023 – Jul 2026) | $149 | $146 |
| 5 years (Aug 2021 – Jul 2026) | $144 | $142 |
| Since data start (Aug 2019 – Jul 2026) | $197 | $186 |
SWERX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +8.18% |
| 1 year | +17.03% |
| 3 years (annualised) | +14.13% |
| 5 years (annualised) | +7.50% |
SWERX Annual Returns
Calendar-year total returns of Schwab Target 2040 Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +8.18% |
| 2025 | +17.70% |
| 2024 | +12.79% |
| 2023 | +19.06% |
| 2022 | −18.68% |
| 2021 | +15.66% |
| 2020 | +14.44% |
| 2019 (Aug–Dec) | +6.99% |
SWERX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +2.6% | +1.8% | −5.6% | +7.0% | +3.3% | 0.0% | −0.7% | — | — | — | — | — |
| 2025 | +2.9% | −0.1% | −3.1% | +0.6% | +4.1% | +3.8% | +0.4% | +2.8% | +2.6% | +1.5% | +0.5% | +0.6% |
| 2024 | +0.1% | +3.5% | +2.7% | −3.7% | +4.1% | +1.4% | +2.2% | +2.2% | +1.5% | −2.2% | +3.6% | −3.0% |
| 2023 | +7.1% | −2.7% | +2.2% | +1.0% | −1.0% | +5.0% | +2.8% | −2.3% | −4.2% | −2.8% | +8.1% | +5.2% |
| 2022 | −4.9% | −3.0% | +1.0% | −7.3% | +0.4% | −7.5% | +6.6% | −4.1% | −8.7% | +5.5% | +7.0% | −3.8% |
| 2021 | −0.3% | +2.3% | +2.1% | +4.0% | +1.2% | +1.3% | +1.0% | +2.0% | −3.8% | +4.0% | −2.1% | +3.2% |
| 2020 | −1.0% | −5.9% | −13.0% | +9.8% | +4.5% | +2.8% | +4.5% | +4.6% | −2.4% | −1.8% | +9.7% | +4.0% |
| 2019 | — | — | — | — | — | — | — | −1.6% | +1.3% | +2.1% | +2.4% | +2.6% |
SWERX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 10.70%
- 3-year Sharpe ratio: 0.90 (vs 4.5% risk-free rate)
- Best month: +8.06% (Nov 2023)
- Worst month: −5.58% (Mar 2026)
SWERX Fund Flows
Monthly money in and out of Schwab Target 2040 Fund, from SEC Form N-PORT.
- 12-month net flow: −$51.3M
- 12-month gross sales (incl. reinvestments): $185.4M
- Sales ÷ redemptions: 0.78×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $8.7M | $16.7M | −$8.1M |
| Jun 2026 | $6.9M | $18.7M | −$11.8M |
| May 2026 | $7.0M | $77.2M | −$70.2M |
| Apr 2026 | $8.7M | $13.7M | −$5.0M |
| Mar 2026 | $7.4M | $13.2M | −$5.8M |
| Feb 2026 | $9.0M | $14.2M | −$5.1M |
| Jan 2026 | $12.5M | $16.6M | −$4.1M |
| Dec 2025 | $93.3M | $8.9M | $84.4M |
| Nov 2025 | $9.3M | $11.0M | −$1.7M |
| Oct 2025 | $7.4M | $12.8M | −$5.4M |
| Sep 2025 | $8.4M | $22.9M | −$14.5M |
| Aug 2025 | $6.7M | $10.8M | −$4.1M |
SWERX Assets Under Management
Net assets of Schwab Target 2040 Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $1.32B |
| 2026-04-30 | $1.37B |
| 2026-01-31 | $1.35B |
| 2025-10-31 | $1.31B |
| 2025-07-31 | $1.25B |
| 2025-04-30 | $1.16B |
| 2025-01-31 | $1.21B |
| 2024-10-31 | $1.18B |
| 2024-07-31 | $1.18B |
| 2024-04-30 | $1.11B |
| 2024-01-31 | $1.10B |
| 2023-10-31 | $981.61M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.